The Human CD30/TNFRSF8 Antibody from R&D Systems is a goat polyclonal antibody to CD30/TNFRSF8. This antibody reacts with human. The Human CD30/TNFRSF8 Antibody has been validated for the following applications: Western Blot, Agonist Activity, Immunocytochemistry.
Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human CD30, Phe19-Lys379, Accession # P28908
Detects human CD30 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant mouse CD30 is observed.
<0.10 EU per 1 µg of the antibody by the LAL method.
catalog number base :
Western Blot, Agonist Activity, Immunocytochemistry
applications abr :
WB, AgAct, ICC
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.